The company plans to make the new facility as the commercial-scale plant for its LinkSeq product line.
Linkage Biosciences CEO Zachary Antovich said the facility meets the company’s process requirements and provides more production capacity than the previous facility.
"In addition, these new facilities accommodate our expanding R&D, regulatory and administrative needs," Antovich added.
"This facility is ready to be a part of our ISO 13485 certification and other regulatory efforts including CE and FDA regulatory filings."